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In di rect costs of cer vi cal 
and breast can cers in Spain
Breast can cer is the tu mor with the high-
est prev a lence rate in wom en in in dus tri-
al ized coun tries and the sec ond most fre-
quent cause of death in wom en in Spain 
af ter cor o nary dis ease. In the year 2000 
breast can cer caused 5,663 deaths. The 
in ci dence of breast can cer in creas es af ter 
the age of 40 years, al though most of the 
deaths are in pa tients aged over 65 (62) 
[12]. Nev er the less the sur vival rate at 
5 years in Spain ranges from 69 to 72 
[23] due to ear ly di ag no sis and ad vances 
in ther a py. In Spain cer vi cal can cer caused 
594 deaths in the year 2000, 313 in wom-
en un der aged 65 (near ly 53). The ae tar i-
an groups most af fect ed by cer vi cal can cer 
range are those aged 45–64 years, and the 
sur vival rate at 5 years is about 58–66.
The in ci dence of both types of can-
cer has in creased in Spain dur ing re cent 
decades but is still low er than in North 
Amer i ca and in oth er west ern Eu ro pean 
coun tries but is high er than in East ern Eu-
rope, Asia, and Africa [28]. Both types of 
can cer are re lat ed to ge net ic pre dis po si-
tion, hor mon al state, and an thro po met ric 
fea tures but are also in flu enced by life-style 
(diet, seden tarism, smok ing and drink ing 
habits, re pro duc tive fac tors) and by cul tur-
al and en vi ron men tal fac tors [17, 35].
Breast and cer vi cal can cers are a pri or i-
ty for Span ish health au thor i ties be cause of 
their im por tance and the avail abil i ty of ef-
fec tive pre ven tive in ter ven tions that re duce 
their in ci dence (e.g., see [3, 4, 9, 20, 24]). 
The Span ish Min istry of Health has re cent ly 
in clud ed the as sess ment of cost of ill ness in 
the re search stud ies that it pro motes to eval-
u ate the over all im pact of dis eases [29].
Re sources should not be al lo cat ed on 
the ba sis of dis ease costs but ac cord ing to 
the ben e fits of in ter ven tion [30]. Stud ies es-
ti mat ing dis ease costs can, how ev er, help in 
il lus trat ing the ac tu al mag ni tude of health 
prob lems. Cost-of-ill ness stud ies are use ful 
for quan ti fy ing the op por tu ni ty costs of re-
sources de vot ed to health care, and oth er 
pur pos es, and the loss in pro duc tion, be-
cause of ill health. They also of fer valu able 
in for ma tion to the au thor i ties and so ci ety at 
large about the rel a tive and ab so lute im pact 
of health prob lems, there fore help ing in the 
es tab lish ment of pri or i ties. For in stance, 
costs of pre ven tive treat ments can be com-
pared to costs of in ad e quate treat ment, or to 
costs aris ing from ab sence of treat ment.
The sci en tif ic lit er a ture of fers only a 
few stud ies deal ing with in di rect costs of 
can cer. Most of these stud ies fol low the 
hu man cap i tal (HC) ap proach, with in di-
rect costs cov er ing a sub stan tial part of to-
tal costs [1, 23, 27, 34]. An al ter na tive meth-
od is known as the fric tion costs (FC) ap-
proach. The method olog i cal dis cus sion 
about the rel a tive ad van tages and dis ad-
van tages of these per spec tives is con tin-
u ing. The two ap proach es reach very dif-
fer ent re sults, with low er val ues in the FC 
meth od. Koop man schap et al. [19] found 
sig nif i cant dif fer ences be tween them. Fur-
ther stud ies fol low ing both HC and FC 
points of view have as sessed the costs of 
mi graine [22], men tal ill ness [25], cor o nary 
dis eases [23, 31], can cer [23], and back and 
neck pain [5, 11].
The aim of the pres ent study was to con-
tribute to the de bate on HC and FC meth-
ods and to of fer rel e vant in for ma tion to 
the health de ci sion mak er for es ti mat ing 
in di rect costs as so ci at ed with an nu al mor-
bid i ty and mor tal i ty caused by cer vi cal 
and breast can cers in Spain by us ing the 
two al ter na tive per spec tives.
Meth ods
Def i ni tion of “in di rect cost”
The con cept of in di rect cost is still un der 
dis cus sion in the field of eco nom ic eval u a-
tion. Two fun da men tal ques tions – “what 
does in di rect cost mean and “how should in-
di rect cost be eval u at ed” – re main an swered 
Ta ble 1
Dis tri bu tion by age of the num ber of wom en dead due to breast and cer vi cal 
can cers in Spain for the year 2000 (from Span ish Deaths Reg is try and our 
own elab o ra tion)
Age (years) Breast can cer Cer vi cal can cer
 0–24     5   0
25–44   447 101
45–64 1,707 212
65–74 1,359 127
75+ 2,145 154
Total 5,663 594
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about deaths by ba sic cause ac cord ing to 
the In ter na tion al Clas si fi ca tion of Dis-
eases (ICD). The ba sic cause of death is de-
fined as the dis ease or in ju ry that start ed 
the chain of patho log i cal events driv ing 
di rect ly to the death or the cir cum stances 
of the ac ci dent or vi o lence that pro duced 
the dead ly in ju ry. ICD codes 174, 175, and 
180, clin i cal mod i fi ca tion (ICD-9-CM), 
were used to iden ti fy deaths di rect ly at-
tributable to breast and cer vi cal can cers. 
The data cor re spond to year 2000, the lat-
est avail able at the time of the study. We 
as sume that data have not sig nif i cant ly 
changed since then.
The num ber of per sons with per ma nent 
dis abil i ty was ob tained from a study con duct-
ed by the Span ish In sti tute of the So cial Se-
cu ri ty (M.D. Car ba jo-Sotil lo et al., per son al 
com mu ni ca tion, 2003) re ly ing upon a sta tis-
ti cal ly sig nif i cant ran dom sam ple of 1,757 cas-
es of per ma nent dis abil i ty for the year 2001. 
To ex trap o late these fig ures to the na tion al 
lev el we used data on ear ly re tire ments due 
to per ma nent dis abil i ty (from the same In sti-
tute). Data on tem po rary dis abil i ty were ob-
tained from sta tis tics con cern ing the Ca nary 
Is lands (pop u la tion 1.78 mil lion in 2001, com-
pared to the Span ish pop u la tion of 42 mil-
lion; INE: http://www.ine.es/inebase/menu1.
htm#5) and were ex trap o lat ed to the na tion-
al to tal fig ures, con trolled by the size of the 
la bor mar kets and the epi demi o log i cal vari-
abil i ty in this re gion, with re spect to the 
Span ish la bor mar ket and the na tion al epi-
demi o log i cal re sults. La bor pro duc tion lost 
is es ti mat ed by fe male gross wages. Fe male 
wages were ob tained from the In dus try and 
Ser vices Wages Sur vey [13]. Fe male em ploy-
ment rates by age were ob tained from the Ac-
tive Pop u la tion Sur vey [14]. Costs were up-
dat ed to the year 2003.
Es ti ma tion meth ods
Re gard ing deaths were es ti mat ed years of 
po ten tial life lost (YPLL) and years of po-
work when they re turn to work; cowork ers 
can re place them in ur gent tasks, and non 
ur gent tasks can be can celed. In the case of 
per ma nent dis abil i ty or ear ly mor tal i ty the 
work er would be re placed by an oth er per-
son from the un em ployed pool, fill ing the 
va cant po si tion. In the FC mod el pro duc tiv-
i ty loss due to tem po rary dis abil i ty is low er 
than in the HC ap proach. In a long-term 
per spec tive, af ter an ad just ment or “fric-
tion pe ri od,” pro duc tion loss would be zero. 
This ap proach pre sumes that in di vid u al pro-
duc tion lost by a sick work er is not com pa-
ra ble to pro duc tion loss from a so cial point 
of view be cause an un used re source fills the 
gap (the re place ment work er).
Dif fer ences be tween costs es ti ma tions 
us ing HC vs. FC de pend on three ba sic 
el e ments: la bor flex i bil i ty (the ca pa bil i ty 
of de lay ing and/or can cel ing non ur gent 
tasks and of per form ing the most ur gent 
ones), un em ploy ment rate, and length of 
time with “fric tion costs.” The high er the 
flex i bil i ty and the un em ploy ment rate, 
the greater is the dif fer ence be tween the 
re spec tive es ti mates. The short er the fric-
tion pe ri od, the greater is the dif fer ence.
Data
Data on deaths caused by breast and cer-
vi cal can cers were ob tained from the 
Span ish Reg is try of Deaths by cause [12]. 
This data source gives year ly in for ma tion 
in var i ous ways. A wider in ter pre ta tion of in-
di rect costs adds up the com plete time loss 
due to ill ness [6]. How ev er, the most com-
mon def i ni tion for in di rect cost is re strict-
ed to the loss of la bor pro duc tiv i ty due to 
ill health. The pres ent study es ti mates an nu-
al la bor pro duc tiv i ty loss, dis tin guish ing be-
tween costs stem ming from ear ly mor tal i ty 
and costs stem ming from mor bid i ty (tem po-
rary and per ma nent dis abil i ty).
The HC ap proach has been the most 
com mon ly used meth od for mea sur ing 
and eval u at ing pro duc tiv i ty loss [10, 26, 
33]. This meth od as sumes that when a 
work er leaves the la bor mar ket, his/her la-
bor pro duc tiv i ty is lost un til the work er re-
turns to work, in the case of tem po rary 
dis abil i ty, or un til the end of his/her work-
ing life, in the case of per ma nent dis abil-
i ty. Wages pro vide a rea son able mea sure 
for as sess ing la bor fac tor pro duc tiv i ty [2, 
7, 8]. The HC ap proach has a strong eco-
nom ic tra di tion and takes a so cial per spec-
tive, re ly ing on ac count ed and avail able 
data. How ev er, from a the o ret i cal point of 
view the HC meth od has been crit i cized, 
ar gu ing the su pe ri or i ty of con tin gent val-
u a tion meth ods (will ing ness to pay in or-
der to avoid ill ness-re lat ed prob lems). The 
prac ti cal use of these meth ods, how ev er, 
also pre sents prob lems [32].
An al ter na tive is the FC meth od [18]. 
The main idea here is that work ers with 
tem po rary dis abil i ty can make up for lost 
Ta ble 2
Dis tri bu tion by age of the Years of Po ten tial Life Lost (YPLL) caused by 
pre ma ture mor tal i ty of breast and cer vi cal can cers in Spain for the year 2000 
(from Span ish Deaths Reg is try and our own elab o ra tion)
Age (years) Breast can cer Cer vi cal can cer
 0    235     0
25 13,414 3,057
45 23,064 3,189
65+  1,312   136
Total 38,025 6,382
Ta ble 3
Num ber of deaths in wom en aged un der 65 years and the num ber of years of po ten tial pro duc tive life lost (YPPLL) due 
to breast and cer vi cal can cers in Spain for the year 2000 (from Span ish Deaths Reg is try and our own data)
Breast can cer Cer vi cal can cer
Deaths  2,159   313
YPPLL 28,077 4,994
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ten tial pro duc tive life lost (YP PLL) us ing 
a sim ple meth od due to the fact that the 
prob a bil i ties of mor tal i ty for wom en aged 
un der than 65 years is min i mal. For es ti ma-
tion of YPLL we fol lowed the pro ce dure 
of the Span ish Na tion al Sta tis tics In sti tute 
(INE). This in di ca tor shows the ex tent of 
mor tal i ty from a cer tain cause that could 
the o ret i cal ly be avoid ed, con sid er ing the 
to tal num ber of life years lost due to pre-
ma ture death in a giv en pop u la tion. YPLL 
was es ti mat ed for the age range 1–69.
The next step was to trans form YPLL 
into YP PLL. For this we es ti mat ed the 
num ber of to tal deaths oc curred at work-
ing age or be fore 16 years (age of en try 
into the la bor mar ket is 16). The age of exit 
from the la bor mar ket was con sid ered to 
be the le gal age of re tire ment, i.e., 65 years. 
This means that YP PLL is equal to zero for 
deaths oc cur ring af ter age 65. When es ti-
mat ing YPLL and YP PLL no dis count rate 
was used. How ev er, when es ti mat ing costs 
we did ad just data with the fe male em ploy-
ment rate (ad just ed by age) and up dat ed 
with the ap pro pri ate dis count rate and an-
nu al pro duc tiv i ty growth rate.
Costs due to ear ly mor tal i ty were es ti-
mat ed as the pres ent mon e tary val ue of the 
flow of pro duc tion along time lost as a re-
sult of the death. The HC ap proach states 
that if per sons had not died pre ma ture ly, 
they would have con tin ued be ing pro duc-
tive for a cer tain num ber of years, un til the 
age of re tire ment. These years were es ti mat-
ed as the dif fer ence be tween the le gal age of 
re tire ment and the age of death. We con sid-
er deaths of girls and teenagers girls due to 
breast can cer (no deaths have been re port-
ed due to cer vi cal can cer be fore the age 
of 24 years) be cause if dis ease pre ven tion 
avoids death the per son con cerned would 
en ter the la bor mar ket at the age of 16. In 
this way ev ery girl dy ing be fore the age of 
16, rep re sents 49 YP PLL (65 less 16 years).
An nu al fe male wages lost due to breast 
and cer vi cal can cers were ad just ed by em-
ploy ment rates by age in ev ery case of death. 
The ad just ment is nec es sary be cause only 
a cer tain pro por tion of wom en of work ing 
age hold a paid job, and only in these cas es 
should the loss of la bor pro duc tiv i ty be es ti-
mat ed (con sid er ing both em ploy ment rate 
and fe male gross wage the ef fect of high er 
fe male part-time em ploy ment is record ed). 
The ad just ed wages are up dat ed to the ref er-
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Ab stract
This study es ti mat ed the in di rect costs (pro-
duc tiv i ty loss) caused by mor tal i ty and mor-
bid i ty of cer vi cal and breast can cers in Spain. 
We used two al ter na tive meth ods: (a) the tra-
di tion al hu man cap i tal (HC) ap proach and 
(b) the fric tion cost (FC) meth od. The an nu-
al costs were €43.4 and 288.7 for cer vi cal 
and breast can cer, re spec tive ly, by the HC ap-
proach and €1.1 and 11.6 mil lion by the FC 
ap proach. Cost-of-ill ness stud ies help to il-
lus trate the real di men sion of health prob-
lems and should be a ma jor con cern for 
health poli cies. In di rect costs are rel e vant in-
for ma tion about dis eases. How ev er, the es ti-
mat ed in di rect costs de pend heav i ly on the 
ap proach adopt ed.
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ence year (2003). The base line case takes 
up zero for both dis count rate and an nu al 
growth of la bor pro duc tiv i ty. Then the an-
nu al dis count rate was changed be tween 
0–6 and the an nu al growth rate for la bor 
pro duc tiv i ty be tween 0–3 as ex er cis es in 
the sen si tiv i ty anal y sis.
To es ti mate FC our base line case as-
sumes that if per ma nent la bor leaves (ear-
ly mor tal i ty and per ma nent la bor dis abil-
i ty), the cost for the em ploy er of find ing 
and train ing a re place ment is equiv a lent 
to the wage paid for the work per formed 
in 2.5 months, or 75 days (“fric tion pe ri-
od”). This is count ed for per sons dy ing 
be tween the ages of 16 and 65 years [18, 
19] cor rect ed by the Span ish fe male em-
ploy ment rates ad just ed by age. For the 
sen si tiv i ty anal y sis we as sessed costs over 
a lon ger “fric tion pe ri od” of 3.5 months 
(105 days).
An oth er com po nent of in di rect costs 
is per ma nent dis abil i ty. Pro duc tiv i ty loss 
is es ti mat ed in a way sim i lar to the pro ce-
dure fol lowed for ear ly mor tal i ty. There 
is no need for ad just ment to em ploy ment 
rates by ei ther meth ods (HC and FC), as 
data re fer to wom en in the la bor mar ket. 
We must, how ev er, clar i fy an im por tant 
point con cern ing costs due to per ma nent 
dis abil i ty. Per sons re tir ing from the la bor 
mar ket due to the tu mors may die be fore 
the age of 65. If we add up for the same 
in di vid u al pro duc tion loss due to per ma-
nent dis abil i ty and pro duc tion loss due to 
ear ly mor tal i ty, we would be com mit ting 
dou ble ac count ing. To avoid this the re-
sults are ad just ed by us ing sur vival rates 
[23]. (In Spain per ma nent dis abil i ty pen-
sions are nor mal ly award ed af ter a pe ri od 
of 18 months out of work due to ill ness. If 
the pe ri od of la bor in ac tiv i ty is low er than 
18 months, we con sid er it as a case of tem-
po rary dis abil i ty.) Tem po rary dis abil i ty is 
rep re sent ed by the pro duc tiv i ty lost when 
in di vid u als can not work for a cer tain pe ri-
od of time due to ill ness or dis abil i ty. To as-
cer tain these costs we used fe male wages 
and the num ber of work ing days lost for 
ev ery em ployed in di vid u al. In the FC ap-
proach in di vid u al data are cen sored at a 
max i mum of 75 days (105 in the sen si tiv i-
ty anal y sis). Since breast can cer af fects al-
most ex clu sive ly fe males (more than 99 
of cas es), we omit ted males when eval u at-
ing in di rect costs.
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Re sults
Breast can cer to day af fects a high er num-
ber of wom en and at a more ad vanced age 
than cer vi cal can cer. . Ta ble 1 shows that 
most deaths caused by both can cers (62) 
oc curred af ter re tire ment age. YPLL due 
to breast can cer reached 38,025 and that 
due to cer vi cal can cer 6,382 (. Ta ble 2). 
The YP PLL fig ure is 28,077 for breast can-
cer and 4,994 for cer vi cal can cer (. Ta-
ble 3).
. Ta ble 4 shows in di rect costs caused by 
breast and cer vi cal can cers in Spain ac cord-
ing to the two ap proach es. In the base line 
case an nu al dis count rate an an nu al growth 
of la bor pro duc tiv i ty are 0 (HC ap proach) 
and the “fric tion pe ri od” 2.5 months (FC ap-
proach). By the HC ap proach in di rect costs 
as so ci at ed with breast can cer reach €288.7 
mil lion and those as so ci at ed with cer vi cal 
can cer €43.4 mil lion. By the FC ap proach 
the fig ures are €11.6 mil lion and €1.1 mil-
lion, re spec tive ly. In breast can cer the HC 
meth od gives per ma nent dis abil i ty as the 
main cause of pro duc tiv i ty loss, fol lowed 
by ear ly mor tal i ty. In cer vi cal can cer in di-
rect costs are sim i lar for ear ly mor tal i ty and 
per ma nent dis abil i ty. This re sult can be ex-
plained by the high er sur vival rate of wom-
en suf fer ing from breast can cer com pared 
to cer vi cal can cer. By the FC ap proach in 
cer vi cal can cer in di rect costs are sim i lar 
in the three sit u a tions, tem po rary dis abil i-
ty, per ma nent dis abil i ty, and ear ly mor tal-
i ty. Re gard ing breast can cer in di rect costs 
caused by per ma nent dis abil i ty are high er 
than the oth er two fac tors.
It is im por tant to high light the re mark-
able dif fer ences ob served be tween the re-
sults ob tained by the two per spec tives. In-
di rect costs es ti mat ed by the FC ap proach 
are much low er than those es ti mat ed by 
the HC meth od. The dif fer ence de pends 
on the cost item con sid ered. The most 
im por tant dif fer ences are found in costs 
caused by ear ly mor tal i ty and per ma nent 
dis abil i ty, where FC costs are in a range 
as low as 1.5–3.4 of HC costs. For tem-
po rary dis abil i ty the costs by the FC ap-
proach range be tween 24 and 37 of in di-
rect costs ob tained by the HC ap proach.
The above re sults (. Ta ble 4) are based 
on the as sump tion that the dis count rate and 
the growth of la bor pro duc tiv i ty are zero, not 
a re al is tic hy pothe ses. To be more re al is tic 
in the sen si tiv i ty anal y sis we es ti mat ed the 
loss of la bor pro duc tiv i ty (HC) for dif fer ent 
rates (see . Ta ble 5). The sen si tiv i ty anal y sis 
for the FC ap proach (. Ta ble 6) varies the 
fric tion pe ri od from 2.5 months (75 days) to 
3.5 months (105 days). . Ta ble 6 also shows 
how in di rect costs change ac cord ing ly a 
more plau si ble sce nario (1 an nu al growth 
Ta ble 4
In di rect costs (eu ros) of breast and cer vi cal can cers for the year 2003 (from 
our own data)
Pre ma ture 
mor tal i ty
Per ma nent 
dis abil i ty
Tem po rary 
dis abil i ty
Total
HC meth od
· Breast can cer
· Cer vi cal can cer
113,055,606
 21,701,097
159,295,201
 20,565,112
16,381,077
 1,161,016
288,731,884
 43,427,225
FC meth od
· Breast can cer
· Cer vi cal can cer
  2,287,455
    393,161
  5,452,925
    310,801
 3,880,586
   432,068
 11,620,966
  1,136,030
FC vs. HC
· Breast can cer
· Cer vi cal can cer
2%
1.8%
3.4%
1.5%
23.7%
37.2%
4%
2.6%
Ta ble 5
Sen si tiv i ty anal y sis of in di rect costs (eu ros) of breast and cer vi cal can cers 
es ti mat ed by the hu man cap i tal ap proach for the year 2003 us ing dif fer ent 
an nu al growth rates for la bor pro duc tiv i ty and an nu al dis count rates 
(from our own data)
An nu al dis count rate
0% 3% 6%
0% growth
· Breast can cer
· Cerv cal can cer
288,731,884
 43,427,225
256,757,516
 35,020,197
229,354,607
 29,309,194
1% growth
· Breast can cer
· Cer vi cal can cer
308,509,276
 47,085,823
267,995,863
 37,503,121
238,104,452
 31,078,560
2% growth
· Breast can cer
· Cer vi cal can cer
325,002,957
 51,250,152
280,206,139
 40,289,566
247,521,069
 33,039,895
Ta ble 6
Sen si tiv i ty anal y sis of in di rect costs (eu ros) of breast and cer vi cal can cers 
by the fric tion cost ap proach for the year 2003 and FC vs. HC re sults 
(1–3% sce nario)
Type of tu mor Pre ma ture 
mor tal i ty
Per ma nent 
dis abil i ty
Tem po rary 
dis abil i ty
Total
FC (2.5 months)
· Breast can cer
· Cer vi cal can cer
2,287,455
  393,161
5,452,925
  310,801
3,880,586
  432,068
11,620,966
 1,136,030
FC (3.5 months)
· Breast
· Cer vi cal can cer
3,202,437
  550,425
7,634,095
  435,122
5,166,305
  531,624
16,002,837
 1,517,171
FC (2.5–3.5 months) vs. HC
· Breast can cer
· Cer vi cal can cer
(2.3–3.2%)
(2.1–2.9%)
(3.6–5.0%)
(1.8–2.5%)
(23.7–31.5%)
(37.2–45.8%)
(4.3–5.9%)
(3.0–4.0%)
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rate for la bor pro duc tiv i ty and a 3 dis count 
rate) with the re sults ob tained by the FC 
meth od. As can be seen, the re sults of . Ta-
ble 6 con firm the re mark able vari a tions in 
the es ti ma tions of in di rect costs de pend ing 
on the meth o dol o gy used. By the FC meth-
od the in di rect costs are 4.3–5.8 (breast can-
cer) and 3.0–4.0 (cer vi cal can cer) of those 
de ter mined by the HC meth od.
Con clu sions
Screen ing and treat ment of breast and cer-
vi cal can cers are two main pri or i ties for 
Span ish health au thor i ties. To geth er with 
epi demi o log i cal data and health care costs, 
in di rect costs can help to re veal the so cioe-
co nom ic im pact of dis eases. Our study fol-
lows the most com mon def i ni tion for in di-
rect cost (loss of la bor pro duc tiv i ty due to 
ill health) us ing the two most com mon ap-
proach es, HC and FC. We ob served sharp 
vari a tions in the re sults de pend ing on the 
meth od used. There is no doubt that in di-
rect costs are a com po nent of great im por-
tance and sig nif i cance in the to tal costs of 
many dis eases. How ev er, the con cept of in-
di rect costs en tails nu mer ous unan swered 
method olog i cal dif fi cul ties as well as such 
fun da men tal ques tions as “what does in di-
rect cost mean” and “how should in di rect 
cost be eval u at ed”. There are sev er al ar gu-
ments and opin ions about the best meth-
od for as sess ing in di rect costs putting fuel 
to a heat ed de bate. The HC ap proach es ti-
mates a po ten tial loss of pro duc tiv i ty. This 
meth od has been strong ly crit i cized but it 
is based on eco nom ic the o ry, and some 
au thors con sid er that it pro vides the low-
er lim it of the will ing ness to pay for an in-
di vid u al to im prove his/her health [16]. 
The FC meth od is an eclec tic meth od that 
seeks re al is tic es ti ma tions of la bor pro duc-
tiv i ty loss but has been strong ly crit i cized 
be cause of con tra dic tions of eco nom ic the-
o ry [15, 21]. A wider in ter pre ta tion of the 
con cept of in di rect cost should in clude, 
ide al ly, oth er con cepts, such as the prod-
uct gen er at ed by house work or the leisure 
time sac ri ficed in or der to ap proach the 
real loss of so cial wel fare. How ev er, in for-
ma tion sys tems and na tion al ac counts are 
still far from pro vid ing re li able data to sup-
port this type of anal y sis
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